//--> //--> //-->
Toggle navigation
Logout
Change account settings
EN
DE
ES
FR
A-Z
Beta
About EconBiz
News
Thesaurus (STW)
Research Skills
Help
EN
DE
ES
FR
My account
Logout
Change account settings
Login
Publications
Events
Your search terms
Search
Retain my current filters
~type:"book"
Search options
All Fields
Title
Exact title
Subject
Author
Institution
ISBN/ISSN
Published in...
Publisher
Open Access only
Advanced
Search history
My EconBiz
Favorites
Loans
Reservations
Fines
You are here:
Home
Search: subject:"Siltuximab"
Narrow search
Delete all filters
| 1 applied filter
Year of publication
From:
To:
Subject
All
Access to Medicines
4
Affordable Medicines
4
Biotherapeutics
4
COVID-19
4
Coronavirus
4
Favipiravir
4
Global Health
4
Health
4
Intellectual Property
4
Pandemic
4
Patent
4
Public Health
4
Remdesivir
4
Ruxolitinib
4
Sarilumab
4
Siltuximab
4
Tocilizumab
4
Arzneimittel
2
European Union (EU)
2
France
2
Gesundheitspolitik
2
Gesundheitsversorgung
2
Gesundheitswesen
2
Health care
2
Health care system
2
Health policy
2
Immaterialgüterrechte
2
Impact assessment
2
India
2
Intellectual property rights
2
Medical sciences
2
Medizin
2
Molnupiravir
2
Nirmatrelvir
2
Patent Offices
2
Patent law
2
Patentrecht
2
Pharmaceuticals
2
TRIPS
2
United Nations Development Programme (UNDP)
2
more ...
less ...
Online availability
All
Free
4
Type of publication
All
Book / Working Paper
Type of publication (narrower categories)
All
Arbeitspapier
2
Graue Literatur
2
Non-commercial literature
2
Research Report
2
Working Paper
2
Language
All
English
4
Author
All
Ravi, Srividya
4
Published in...
All
Research Paper
2
Research paper
2
Source
All
ECONIS (ZBW)
2
EconStor
2
Showing
1
-
4
of
4
Sort
relevance
articles prioritized
date (newest first)
date (oldest first)
1
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
Ravi, Srividya
-
2022
biotherapeutics tocilizumab,
siltuximab
and sarilumab. …
Persistent link: https://www.econbiz.de/10013330854
Saved in:
2
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
Ravi, Srividya
-
2022
biotherapeutics tocilizumab,
siltuximab
and sarilumab. …
Persistent link: https://www.econbiz.de/10013194325
Saved in:
3
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
Ravi, Srividya
-
2020
patent analysis in this report are remdesivir, ruxolitinib and favipiravir, and the biotherapeutics tocilizumab,
siltuximab
…
Persistent link: https://www.econbiz.de/10012490900
Saved in:
4
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
Ravi, Srividya
-
2020
Persistent link: https://www.econbiz.de/10012433647
Saved in:
Results per page
10
25
50
100
250
A service of the
zbw
×
Loading...
//-->